[go: up one dir, main page]

AU7724398A - A melanoma associated antigen, t cell epitopes thereof and methods of using sa me - Google Patents

A melanoma associated antigen, t cell epitopes thereof and methods of using sa me

Info

Publication number
AU7724398A
AU7724398A AU77243/98A AU7724398A AU7724398A AU 7724398 A AU7724398 A AU 7724398A AU 77243/98 A AU77243/98 A AU 77243/98A AU 7724398 A AU7724398 A AU 7724398A AU 7724398 A AU7724398 A AU 7724398A
Authority
AU
Australia
Prior art keywords
methods
associated antigen
cell epitopes
melanoma associated
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77243/98A
Inventor
Robert J Deans
June Kan-Mitchell
Boris R. Minev
Malcolm S. Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of Southern California USC
Original Assignee
University of California
University of Southern California USC
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of Southern California USC, University of California Berkeley filed Critical University of California
Publication of AU7724398A publication Critical patent/AU7724398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • A61K40/11T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/42Cancer antigens
    • A61K40/4271Melanoma antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/57Skin; melanoma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
AU77243/98A 1997-06-06 1998-06-04 A melanoma associated antigen, t cell epitopes thereof and methods of using sa me Abandoned AU7724398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87094197A 1997-06-06 1997-06-06
US08870941 1997-06-06
PCT/US1998/011533 WO1998055133A1 (en) 1997-06-06 1998-06-04 A melanoma associated antigen, t cell epitopes thereof and methods of using same

Publications (1)

Publication Number Publication Date
AU7724398A true AU7724398A (en) 1998-12-21

Family

ID=25356376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77243/98A Abandoned AU7724398A (en) 1997-06-06 1998-06-04 A melanoma associated antigen, t cell epitopes thereof and methods of using sa me

Country Status (2)

Country Link
AU (1) AU7724398A (en)
WO (1) WO1998055133A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795415B1 (en) * 1999-06-28 2003-09-05 Roussy Inst Gustave PEPTIDE COMPOUND DERIVED FROM AN OFFSET ORF OF THE ICE GENE
CA2516128A1 (en) * 2003-02-14 2004-09-02 Sagres Discovery, Inc. Therapeutic targets in cancer
AT502292B1 (en) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology MELANOMA DIAGNOSIS
AU2007218158A1 (en) * 2006-02-22 2007-08-30 Philogen Spa Vascular tumor markers
CN114920822B (en) * 2021-02-02 2023-06-30 复旦大学附属中山医院 T cell receptor for recognizing C7orf50 mutant antigen short peptide and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689551B1 (en) * 1993-03-17 2008-02-20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins

Also Published As

Publication number Publication date
WO1998055133A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
AU2395895A (en) Melanoma antigens
AU9231998A (en) Antigen presenting mesenchymal stem cells
AU4518196A (en) Adjuvant-incorporated cellular antigens: conjugation and methods
AUPO390396A0 (en) Novel promiscuous T helper cell epitopes
AU1281399A (en) Multi-well single-membrane permeation device and methods
AU4992997A (en) Humanized anti-cd11a antibodies
AU4643596A (en) Chimeric antibodies comprising antigen binding sites and b and t cell epitopes
AU1703999A (en) User interface for voice message access
AU8063798A (en) Secretory immunoglobulin produced by single cells and methods for making and using same
AU7422496A (en) NM03 antibody materials and methods
AU3159499A (en) Antigen preparation and use
AU9512498A (en) Portable shampoo bowl
AU1555297A (en) Antigenic modulation of cells
AU1554399A (en) Gas accumulator
AU7724398A (en) A melanoma associated antigen, t cell epitopes thereof and methods of using sa me
AU6954498A (en) Methods for using antagonistic anti-avb3 integrin antibodies
AU8892698A (en) Method for methane conversion
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU2539697A (en) Anti-idiotypic antibody vaccines
AU7572198A (en) Tumor-associated antigen
AU1726695A (en) Turcasarins, novel expanded porphyrins, and uses thereof
AU6736598A (en) Methods for selecting cells and their uses
AU8225398A (en) Biosensor materials and methods
AU1749397A (en) Mycobacterium antigens and methods for their detection
AU5412498A (en) Water-decomposition gas generating device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase